BGI
CLLS

B Group Inc’s Cellectis CLLS Stock Holding History

B Group Inc’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.84M Hold
3,281,501
– – 4.62% 8
2026
Q1 		$10.4M Hold
3,281,501
– – 7.71% 4
2025
Q4 		$15.9M Hold
3,281,501
– – 11.73% 2
2025
Q3 		$9.35M Buy
3,281,501
+25,000
+0.8% +$64.8K 6.88% 6
2025
Q2 		$4.97M Hold
3,256,501
– – 3.82% 6
2025
Q1 		$4.04M Buy
3,256,501
+175,000
+6% +$259K 3.46% 6
2024
Q4 		$5.55M Buy
+3,081,501
New +$5.75M 3.39% 7

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DRD
Dennis R. Delaney $314M AUM 35.76% 1-Year Est. Return

B Group Inc's CLLS Position: Q2 2026 in Review

B Group Inc held its Cellectis (CLLS) position steady in Q2 2026 at 3,281,501 shares worth $9.84M. The position accounts for 4.62% of the portfolio, ranked #8.

B Group Inc first reported a position in CLLS in Q4 2024 and has held it in 7 quarters since. The position peaked at $15.9M in Q4 2025. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • B Group Inc held 3,281,501 shares of Cellectis worth $9.84M as of Q2 2026.
  • B Group Inc left its Cellectis share count unchanged in Q2 2026.
  • Cellectis made up 4.62% of B Group Inc's portfolio in Q2 2026, its #8 holding.
  • B Group Inc first reported a position in Cellectis in Q4 2024 and has held it in 7 quarters since.
  • B Group Inc's Cellectis position peaked at $15.9M in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on B Group Inc's 13F filing for Q2 2026, filed 14 Aug 2026.